Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Lesokhin, Alexander M, Ansell, Stephen M, Armand, Philippe, Scott, Emma C, Halwani, Ahmad, Gutierrez, Martin, Millenson, Michael M, Cohen, Adam D, Schuster, Stephen J, Lebovic, Daniel, Dhodapkar, Madhav, Avigan, David, Chapuy, Bjoern, Ligon, Azra H, Freeman, Gordon J, Rodig, Scott J, Cattry, Deepika, Zhu, Lili, Grosso, Joseph F, Bradley Garelik, M Brigid, Shipp, Margaret A, Borrello, Ivan, Timmerman, John
Published in Journal of clinical oncology (10.08.2016)
Published in Journal of clinical oncology (10.08.2016)
Get full text
Journal Article
Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)
Kantarjian, Hagop M., Shah, Neil P., Cortes, Jorge E., Baccarani, Michele, Agarwal, Mohan B., Undurraga, María Soledad, Wang, Jianxiang, Kassack Ipiña, Juan Julio, Kim, Dong-Wook, Ogura, Michinori, Pavlovsky, Carolina, Junghanss, Christian, Milone, Jorge H., Nicolini, Franck E., Robak, Tadeusz, Van Droogenbroeck, Jan, Vellenga, Edo, Bradley-Garelik, M. Brigid, Zhu, Chao, Hochhaus, Andreas
Published in Blood (02.02.2012)
Published in Blood (02.02.2012)
Get full text
Journal Article
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
Kantarjian, Hagop, Shah, Neil P, Shah, Sandip, Hochhaus, Andreas, Cortes, Jorge, Ayala, Manuel, Moiraghi, Beatriz, Shen, Zhixiang, Mayer, Jiri, Pasquini, Ricardo, Nakamae, Hirohisa, Huguet, Françoise, Boqué, Concepción, Chuah, Charles, Bleickardt, Eric, Bradley-Garelik, M. Brigid, Zhu, Chao, Szatrowski, Ted, Shapiro, David, Baccarani, Michele
Published in The New England journal of medicine (17.06.2010)
Published in The New England journal of medicine (17.06.2010)
Get full text
Journal Article
Dasatinib in Imatinib- Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study: Efficacy and Tolerability of 140 Milligrams Once Daily and 70 Milligrams Twice Daily
SAGLIO, Giuseppe, HOCHHAUS, Andreas, CHAO ZHU, DOMBRET, Herve, YEOW TEE GOH, MASSZI, Tamas, PASQUINI, Ricardo, MALOISEL, Frederic, ERBEN, Philipp, CORTES, Jorge, PAQUETTE, Ronald, BRADLEY-GARELIK, M. Brigid
Published in Cancer (15.08.2010)
Published in Cancer (15.08.2010)
Get full text
Journal Article
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up
Kantarjian, Hagop, Cortes, Jorge, Kim, Dong-Wook, Dorlhiac-Llacer, Pedro, Pasquini, Ricardo, DiPersio, John, Müller, Martin C., Radich, Jerald P., Khoury, H. Jean, Khoroshko, Nina, Bradley-Garelik, M. Brigid, Zhu, Chao, Tallman, Martin S.
Published in Blood (18.06.2009)
Published in Blood (18.06.2009)
Get full text
Journal Article
Integrated analysis of randomized controlled trials evaluating bortezomib + lenalidomide + dexamethasone or bortezomib + thalidomide + dexamethasone induction in transplant-eligible newly diagnosed multiple myeloma
Rosiñol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Ríos Tamayo, Rafael, Hulin, Cyrille, Blanchard, María Jesús, Caillot, Denis, Sureda, Anna, Hernández, Miguel Teodoro, Arnulf, Bertrand, Mateos, Maria-Victoria, Macro, Margaret, San-Miguel, Jesús, Belhadj, Karim, Lahuerta, Juan José, Garelik, M. Brigid, Bladé, Joan, Moreau, Philippe
Published in Frontiers in oncology (02.11.2023)
Published in Frontiers in oncology (02.11.2023)
Get full text
Journal Article
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase
Chuah, Charles T., Nakamae, Hirohisa, Shen, Zhixiang X., Bradley-Garelik, M. Brigid, Kim, Dong-Wook
Published in Leukemia & lymphoma (01.09.2014)
Published in Leukemia & lymphoma (01.09.2014)
Get full text
Journal Article
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
Jabbour, Elias, Kantarjian, Hagop M., Saglio, Giuseppe, Steegmann, Juan Luis, Shah, Neil P., Boqué, Concepción, Chuah, Charles, Pavlovsky, Carolina, Mayer, Jiří, Cortes, Jorge, Baccarani, Michele, Kim, Dong-Wook, Bradley-Garelik, M. Brigid, Mohamed, Hesham, Wildgust, Mark, Hochhaus, Andreas
Published in Blood (23.01.2014)
Published in Blood (23.01.2014)
Get full text
Journal Article
Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia
Kim, Dong-Wook, Goh, Yeow-Tee, Hsiao, Hui-Hua, Caguioa, Priscilla B., Kim, Dongho, Kim, Wan-Seok, Saikia, Tapan, Agrawal, Shruti, Roy, Amit, Dai, David, Bradley-Garelik, M. Brigid, Mukhopadhyay, Jaydip, Jootar, Saengsuree
Published in International journal of hematology (01.06.2009)
Published in International journal of hematology (01.06.2009)
Get full text
Journal Article
Cross-Intolerance with Dasatinib Among Imatinib-Intolerant Patients with Chronic-Phase Chronic Myeloid Leukemia
Khoury, Hanna J, Goldberg, Stuart L, Mauro, Michael J, Stone, Richard M, Deininger, Michael W, Bradley-Garelik, M. Brigid, Mohamed, Hesham, Guilhot, François
Published in Clinical lymphoma, myeloma and leukemia (01.06.2016)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2016)
Get full text
Journal Article
Dasatinib in imatinib‐resistant or imatinib‐intolerant chronic myeloid leukemia in blast phase after 2 years of follow‐up in a phase 3 study
Saglio, Giuseppe, Hochhaus, Andreas, Goh, Yeow Tee, Masszi, Tamas, Pasquini, Ricardo, Maloisel, Frederic, Erben, Philipp, Cortes, Jorge, Paquette, Ronald, Bradley‐Garelik, M. Brigid, Zhu, Chao, Dombret, Herve
Published in Cancer (15.08.2010)
Published in Cancer (15.08.2010)
Get full text
Journal Article
Nivolumab in Patients (Pts) with Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL): Clinical Outcomes from Extended Follow-up of a Phase 1 Study (CA209-039)
Ansell, Stephen, Armand, Philippe, Timmerman, John M., Shipp, Margaret A., Bradley Garelik, M Brigid, Zhu, Lili, Lesokhin, Alexander M.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma
Rosinol Dachs, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Rios, Rafael, Hulin, Cyrille, Blanchard, Maria Jesús, Caillot, Denis, Sureda, Anna, Hernández, Miguel T, Arnulf, Bertrand, Mateos, Maria-Victoria, Macro, Margaret, San-Miguel, Jesús F, Belhadj, Karim, Lahuerta, Juan Jose, Chen, Guang, Garelik, M. Brigid, Bladé, Joan, Moreau, Philippe, Attal, Michel
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Integrated Analysis of Bortezomib-Lenalidomide-Dexamethasone vs Bortezomib-Thalidomide-Dexamethasone in Transplant-Eligible Newly Diagnosed Myeloma
Rosinol, Laura, Hebraud, Benjamin, Oriol, Albert, Colin, Anne-Laurène, Tamayo, Rafael Ríos, Hulin, Cyrille, Blanchard, Maria Jesús, Caillot, Denis, Balari, Anna Sureda, Hernandez, Miguel T., Arnulf, Bertrand, Mateos, Maria-Victoria, Macro, Margaret, San-Miguel, Jesus, Belhadj, Karim, Lahuerta, Juan-Jose, Garelik, M. Brigid, Blade, Joan, Moreau, Philippe, Attal, Michel
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Four-Year (Yr) Follow-Up Of Patients (Pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) Receiving Dasatinib Or Imatinib: Efficacy Based On Early Response
Cortes, Jorge E., Hochhaus, Andreas, Kim, Dong-Wook, Shah, Neil P., Mayer, Jiri, Rowlings, Philip, Nakamae, Hirohisa, Bradley-Garelik, M. Brigid, Mohamed, Hesham, Kantarjian, Hagop M., Saglio, Giuseppe
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
Dasatinib versus imatinib (IM) in newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP): DASISION 3-year follow-up
Hochhaus, Andreas, Shah, Neil P., Cortes, Jorge E., Baccarani, Michele, Bradley-Garelik, M. Brigid, Dejardin, David, Kantarjian, Hagop
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A phase II study of dasatinib therapy in children and adolescents with newly diagnosed chronic phase chronic myelogenous leukemia (CML-CP) or Philadelphia chromosome-positive (Ph+) leukemias resistant or intolerant to imatinib
Zwaan, Michel, Stork, Linda C., Bertrand, Yves, Gore, Lia, Hijiya, Nobuko, De Souza, Carmino, de Martino Lee, Maria Lucia, Bradley-Garelik, M. Brigid, Kearns, Pamela
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Dasatinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) In the DASISION Trial: 18-Month Follow-up
Shah, Neil, Kantarjian, Hagop, Hochhaus, Andreas, Cortes, Jorge E., Bradley-Garelik, M. Brigid, Zhu, Chao, Baccarani, Michele
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Safety and Efficacy of Dasatinib Versus Imatinib by Baseline Cardiovascular Comorbidity In Patients with Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Analysis of the DASISION Trial
Saglio, Giuseppe, Hochhaus, Andreas, Cortes, Jorge E., Kantarjian, Hagop, Baccarani, Michele, Bradley-Garelik, M. Brigid, Dejardin, David, Shah, Neil P.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article